See also this year's filing and all EDGAR filings for this company.
PDF Report 0001677077_2021_Alzamend_Neuro_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001677077, Alzamend Neuro Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,814,015 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 992,306 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 3,354,743 |
| 9 | ResearchAndDevelopmentExpense | 1,069,418 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 13,925 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,814,015 |
| 1 | Liabilities | 992,306 |
| 2 | Expenses | 4,424,161 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 821,709 |
| 5 | NetIncome | -4,410,236 |
| 6 | ComprehensiveNetIncome | -4,410,236 |
| 7 | BaseVar | 3,622,204 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -1.87 |
| 9 | EconomicCapitalRatio | 1.07 |
Edgar->Model Mapping
Feature Distribution
